Burimamide

Names
IUPAC name 1-[4-(1H-imidazol-5-yl)butyl]-3-methylthiourea
Identifiers
CAS Number	34970-69-9 Y
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL12160 Y
ChemSpider	2297780 Y
KEGG	C07448 Y
PubChemCID	3032915
UNII	TN5A4OD2TV Y
CompTox Dashboard(EPA)	DTXSID00188519
InChI InChI=1S/C9H16N4S/c1-10-9(14)12-5-3-2-4-8-6-11-7-13-8/h6-7H,2-5H2,1H3,(H,11,13)(H2,10,12,14) Y Key: HXRBAVXGYZUSED-UHFFFAOYSA-N Y InChI=1/C9H16N4S/c1-10-9(14)12-5-3-2-4-8-6-11-7-13-8/h6-7H,2-5H2,1H3,(H,11,13)(H2,10,12,14) Key: HXRBAVXGYZUSED-UHFFFAOYAJ
SMILES CNC(=S)NCCCCc1c[nH]cn1
Properties
Chemical formula	C9H16N4S
Molar mass	212.32 g/mol
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). Y verify (what is YN ?) Infobox references

Burimamide is anantagonist at theH₂ andH₃histaminereceptors. At physiological pH, it is largely inactive as an H₂ antagonist,^[1] but its H₃ affinity is 100x higher. It is athiourea derivative.

Burimamide was first developed by scientists at Smith, Kline & French (SK&F; nowGlaxoSmithKline) in their intent to develop a histamine antagonist for the treatment ofpeptic ulcers.^[2] The discovery of burimamide ultimately led to the development ofcimetidine (Tagamet).^[2]

• Metiamide
• Cimetidine

Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• H2 receptor antagonists
• H3 receptor antagonists
• Imidazoles
• Thioureas
• Gastrointestinal system drug stubs

• Articles containing unverified chemical infoboxes
• Chembox image size set
• Articles with short description
• Short description matches Wikidata
• All stub articles